The acquisition, retention and reversal of spatial learning in the morris water maze task following withdrawal from an escalating dosage schedule of amphetamine in wistar rats

Neuroscience

Volumn 119, Issue 1, 2003, Pages 167-179

  Russig, H ^a   Durrer, A ^a   Yee, B K ^a   Murphy, C A ^a   Feldon, J ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Addiction; Memory; Schizophrenia; Sensitisation

Indexed keywords

AMPHETAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG SENSITIZATION; DRUG WITHDRAWAL; FUNCTIONAL ASSESSMENT; LATENT INHIBITION; LEARNING; MAZE TEST; MEMORY CONSOLIDATION; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; SPATIAL ORIENTATION; SPECIES COMPARISON; TASK PERFORMANCE;

EID: 0037649974     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00045-9     Document Type: Article

References (54)

1. Ahlenius S., Carlsson A., Engel J. Antagonism by baclophen of the d-amphetamine-induced disruption of a successive discrimination in the rat. J Neural Transm. 36:1975;327-333.
2. Baddeley A. Working memory. Science. 255:1992;556-559.
3. Barr A.M., Phillips A.G. Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement. Psychopharmacology. 141:1999;99-106.
4. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron. 25:2000;515-532.
5. Bouton M.E. Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull. 114:1993;80-99.
6. Brady K.T., Lydiard R.B., Malcom R., Ballanger J.C. Cocaine-induced psychosis. J Clin Psych. 52:1991;509-512.
7. Brown R.W., Bardo M.T., Mace D.D., Phillips S.B., Kraemer P.J. D- amphetamine facilitation of Morris water task performance is blocked by eticlopride and correlated with increased dopamine synthesis in the prefrontal cortex. Behav Brain Res. 114:2000;135-143.
8. Bruto V., Anisman H. Acute and chronic amphetamine treatment differential modification of exploratory behavior in a radial maze . Pharmacol Biochem Behav. 19:1983;487-496.
9. Bruto V., Kokkinidis L., Anisman H. Attenuation of perseverative behavior after repeated amphetamine treatment tolerance or attentional deficits? Pharmacol Biochem Behav. 19:1983;497-504.
10. Dias R., Robbins T.W., Roberts A.C. Primate analogue of the Wisconsin Card Sorting Test effects of excitotoxic lesions of the prefrontal cortex in the marmoset . Behav Neurosci. 110:1996;872-886.
11. Ellinwood E.H. Amphetamine psychosis I. Description of the individuals and process . J Nerv Ment Dis. 144:1967;273-283.
12. Escobar M., Arcediano F., Miller R.R. Latent inhibition and contextual associations. J Exp Psychol Anim Behav Process. 28:2002;123-136.
13. Escobar M., Oberling P., Miller R.R. Associative deficit accounts of disrupted latent inhibition and blocking in schizophrenia. Neurosci Biobehav Rev. 26:2002;203-216.
14. Fagan A.M., Olton D.S. Learning sets, discrimination reversal, and hippocampal function. Behav Brain Res. 21:1986;13-20.
15. Gelowitz D.L., Richardson J.S., Wishart T.B., Yu P.H., Lai C.T. Chronic L-deprenyl or L-amphetamine equal cognitive enhancement, unequal MAO inhibition . Pharmacol Biochem Behav. 47:1994;41-45.
16. Goldman-Rakic PS (1987) Circuitry of the primate prefrontal cortex and regulation of behavior by representational memory. In: The nervous system: Handbook of physiology, Vol. 7 (Blum F, Mountcastle S, eds), pp 373-417. Bethesda: American Physiological Society
17. Harmer C.J., Phillips G.D. Enhanced appetitive conditioning following repeated pretreatment with d-amphetamine. Behav Pharmacol. 9:1998;299-308.
18. Janus C., D'Amelio S., Amitay O., Chishti M.A., Strome R., Fraser P., Carlson G.A., Roder J.C., St George-Hyslop P., Westaway D. Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol Aging. 21:2000;541-549.
19. Jentsch J.D., Olausson P., De La Garza R. II, Taylor J.R. Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology. 26:2002;183-190.
20. Killcross A.S., Dickinson A., Robbins T.W. Amphetamine-induced disruptions of latent inhibition are reinforcer mediated implications for animal models of schizophrenic attentional dysfunction . Psychopharmacology (Berl). 115:1994;185-195.
21. Kraemer P.J., Spear N.E. The effect of nonreinforced stimulus exposure on the strength of a conditioned taste aversion as a function of retention interval do intent inhibition and extinction involve a shared process? Anim Learn Behav. 20:1991;1-7.
22. Kraemer P.J., Spear N.E. Retrieval processes and conditioning. Zentall T.R. Animal cognition: a tribute to Donald A. Riley. 1993;87-110 Mahwah, New Jersey.
23. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia implications from recent brain imaging studies . Brain Res Rev. 31:2000;371-384.
24. Lin D., Koob G.F., Markou A. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat-interactions between the two drugs. Psychopharmacology. 145:1999;283-294.
25. Lin D., Koob G.F., Markou A. Time-dependent alterations in ICSS thresholds associated with repeated amphetamine administrations. Pharmacol Biochem Behav. 65:2000;407-417.
26. Lubow R.E. Latent inhibition. Psychol Bull. 79:1973;398-407.
27. Lubow RE (1989) Latent inhibition and conditioned attention theory. Cambridge, UK: Cambridge University Press.
28. Mackintosh NJ (1974) The psychology of animal learning. London: Academic Press.
29. McGaugh J.L. Dissociation learning and performancedrug and hormone enhancement of memory storage. Brain Res Bull. 23:1989;339-345.
30. Moran P.M., Fischer J.M., Hitchcock J.M., Moser P.C. Effects of clozapine on latent inhibition in the rat. Behav Pharmacol. 7:1996;42-48.
31. Murphy C.A., Fend M., Russig H., Feldon J. Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine. Behav Neurosci. 115:2001;1247-1256.
32. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci. 2:2001;119-128.
33. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science. 278:1997;58-63.
34. Paulson P.E., Camp D.M., Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monamine concentrations during amphetamine withdrawal in rats. Psychopharmacology. 103:1991;480-492.
35. Pezze M.A., Feldon J., Murphy C.A. Increased conditioned fear response and altered balance of dopamine in the shell and core of the nucleus accumbens during amphetamine withdrawal. Neuropharmacology. 42:2002;633-643.
36. Post R.M. Cocaine psychosis a continuum model . J Psychiatry. 132:1975;225-231.
37. Quirk P.L., Richards R.W., Avery D.D. Subchronic cocaine produces training paradigm-dependent learning deficits in laboratory rats. Pharmacol Biochem Behav. 68:2001;545-553.
38. Richmond M.A., Murphy C.A., Pouzet B., Schmid P., Rawlins J.N., Feldon J. A computer controlled analysis of freezing behaviour. J Neurosci Methods. 86:1998;91-99.
39. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration a review and evaluation of animal models of amphetamine psychosis . Brain Res Rev. 11:1986;157-198.
40. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci. 17:1997;8491-8497.
41. Russig H., Murphy C.A., Feldon J. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal. Neuropsychopharmacology. 26:2002;765-777.
42. Russig H., Murphy C.A., Feldon J. Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine. Psychopharmacology. 2003.
43. Sandi C., Loscertales M., Guaza C. Experience-dependent facilitating effect of corticosterone on spatial memory formation in the water maze. Eur J Neurosci. 9:1997;637-642.
44. Stefani MR, Moghaddam B (2002) Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat. Behav Brain Res 134:267-274.
45. Sutherland NS, Mackintosh NJ (1971) Mechanisms of animal discrimination learning. New York: Academic Press.
46. Snyder S.H. AMPH psychosis a "model" schizophrenia mediated by catecholamines . Am J Psychiatry. 130:1973;61-67.
47. Taylor J.R., Jentsch J.D. Repeated intermittent administration of psychomotor stimulant drugs alters the acquisition of Pavlovian approach behavior in rats differential effects of cocaine, d-AMPH and 3,4-methylenedioxymethAMPH ("Ecstasy") . Biol Psychiatry. 50:2001;137-143.
48. Warburton E.C., Joseph M.H., Feldon J., Weiner I., Gray J.A. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and odansetron implications for a possible antipsychotic action of odansetron . Psychopharmacology. 114:1994;657-664.
49. Weiner I., Feldon J., Ben-Shahar O. Simultaneous brightness discrimination and reversal the effects of amphetamine administration in the two stages . Pharmacol Biochem Behav. 25:1986;939-942.
50. Weiner I., Feldon J. Reversal and nonreversal shifts under amphetamine. Psychopharmacology. 89:1986;355-359.
51. Weiner I., Lubow R.E., Feldon J. Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav. 30:1988;871-878.
52. Weiner I. Neural substrates of latent inhibition the switching model . Psychol Bull. 108:1990;442-461.
53. Weiner I., Schadach E., Tarrasch R., Kidron R., Feldon J. The latent inhibition model of schizophrenia further validation using the atypical neuroleptic clozapine . Biol Psychiatry. 40:1996;834-843.
54. Weiner I., Feldon J. The switching model of latent inhibition an update of neural substrates . Behav Brain Res. 88:1997;11-25.